BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chandrapalan S, Bosch S, Cubiella J, Guardiola J, Kimani P, Mulder C, Persaud K, de Meij TGJ, Altomare DF, Brenner H, de Boer NKH, Ricciardiello L, Arasaradnam RP. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer. Aliment Pharmacol Ther 2021;54:14-23. [PMID: 34004036 DOI: 10.1111/apt.16405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Withrow DR, Shine B, Oke J, Tamm A, James T, Morris E, Davies J, Harris S, East JE, Nicholson BD. Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care. BMC Med 2022;20:116. [PMID: 35287679 DOI: 10.1186/s12916-022-02272-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 van Liere ELSA, de Boer NKH, Dekker E, van Leerdam ME, de Meij TGJ, Ramsoekh D. Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome. Aliment Pharmacol Ther 2022. [PMID: 35181895 DOI: 10.1111/apt.16824] [Reference Citation Analysis]
3 Chandrapalan S, Bosch S, Tyagi H, Daulton E, Cubiella J, Guardiola J, Kimani P, Mulder C, Covington J, Persaud K, de Meij TGJ, Altomare DF, Brenner H, de Boer NKH, Ricciardiello L, Arasaradnam RP. Editorial: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer-Authors' reply. Aliment Pharmacol Ther 2021;54:506-7. [PMID: 34331793 DOI: 10.1111/apt.16511] [Reference Citation Analysis]
4 Bradley C, Hee SW, Andronis L, Persaud K, Hull MA, Todd J, Taylor-Phillips S, Smith S, Constable R, Waugh N, Arasaradnam RP; RECEDE Study Group. REducing Colonoscopies in patients without significant bowEl DiseasE: the RECEDE Study - protocol for a prospective diagnostic accuracy study. BMJ Open 2022;12:e058559. [PMID: 35354626 DOI: 10.1136/bmjopen-2021-058559] [Reference Citation Analysis]
5 Tyagi H, Daulton E, Bannaga AS, Arasaradnam RP, Covington JA. Non-Invasive Detection and Staging of Colorectal Cancer Using a Portable Electronic Nose. Sensors (Basel) 2021;21:5440. [PMID: 34450881 DOI: 10.3390/s21165440] [Reference Citation Analysis]
6 Hanna GB, Cross AJ. Editorial: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer. Aliment Pharmacol Ther 2021;54:504-5. [PMID: 34331792 DOI: 10.1111/apt.16471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang X, Gui X, Zhang Y, Liu Q, Zhao L, Gao J, Ji J, Zhang Y. A Panel of Bile Volatile Organic Compounds Servers as a Potential Diagnostic Biomarker for Gallbladder Cancer. Front Oncol 2022;12:858639. [PMID: 35433420 DOI: 10.3389/fonc.2022.858639] [Reference Citation Analysis]